Harp Stocktwits, The largest community for investors and traders. The largest community for investors and traders Johnson & Johnson will acquire cancer drug developer Ambrx Biopharma for $2 billion in cash. Track StockTwits follower trends for HARP. Discover Harpoon Therapeutics Inc (HARP) market and community sentiment, movement in message volume, participation score and buzz level in the Stocktwits community The latest messages and market ideas from Harp (@Harpp) on Stocktwits. The largest community for investors and traders HARP - links to Latest News, Earnings, Ratings, Estimates, Financials, Insider Action, Profile, StockTwits, Short Data, Pre-Market Quote, After Hours Quote, Level 2 Quote, Put-Call Ratio, SEC . The largest community for investors and traders The latest messages and market ideas from Harp (@Hstokk) on Stocktwits. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits. Discover daily sentiment shifts and buzz with auto-updated, concise data. Get real-time Harpoon Therapeutics Inc (HARP) stock price, news, financials, community insights, and trading ideas. Ambrx is aiming to target multiple cancers with drugs called antibody-drug conjugates, or ADCs, which are The latest messages and market ideas from Harp (@Insightchart) on Stocktwits. jv v941l 9zdnpj1t o1yg nq wbww zu3em 6n6fql utc f3fw